Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle (179111)

ARTG ID

179111

ARTG Name

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

November 15, 2011

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Arrotex Pharmaceuticals Pty Ltd

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Active Ingredients

Ingredient Name

montelukast sodium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

APO-MONTELUKAST montelukast 4 mg (as sodium) chewable tablet bottle (179111) - TGA 批准文号 | MedPath